Gaxos.ai Inc. (NASDAQ: GXAI) has outlined its post-divestiture operating strategy following the sale of its gaming assets, signaling a focused commitment to expanding its AI applications through Gaxos Labs and the health and wellness offerings of its majority-owned subsidiary, RNK Health. The company reported significant first-quarter 2026 revenue growth of approximately $1.81 million, driven primarily by RNK Health and subscriptions to Gaxos Labs applications.
According to the company, the strategic realignment prioritizes scaling revenue-generating platforms, improving customer acquisition efficiency, advancing commercially focused AI products, and maintaining disciplined capital allocation. Gaxos.ai also said it will continue to hold its 19.99% ownership interest in America First Defense.AI, providing separate reporting on that investment. Additionally, the company plans to enhance investor communications with additional operating performance metrics as its businesses grow.
The announcement underscores Gaxos.ai's transition from a gaming-centric entity to a diversified technology company leveraging artificial intelligence across multiple sectors. Gaxos Labs is positioned as the core hub for AI application development, while RNK Health focuses on personalized health and wellness solutions. The company's portfolio now spans defense, health, entertainment, and productivity.
This strategic pivot comes as Gaxos.ai seeks to capitalize on the growing demand for AI-driven solutions in everyday life and high-impact industries. The company's decision to divest gaming assets reflects a broader trend of firms streamlining operations to concentrate on high-growth areas. With first-quarter revenue already showing strong momentum, Gaxos.ai appears well-positioned to execute its strategy.
Investors and stakeholders are expected to monitor the company's progress in scaling its AI and health platforms. The inclusion of America First Defense.AI as a strategic investment adds a defense-sector dimension to Gaxos.ai's portfolio. For more details, the full press release is available at https://ibn.fm/G9Ld7.
As Gaxos.ai continues to evolve, its focus on AI and health could position it for sustained growth in competitive markets. The company's commitment to investor transparency, including enhanced performance metrics, may also build confidence among shareholders.
